Status:
COMPLETED
High Dose Chemotherapy Followed By PBSC Rescue for HD
Lead Sponsor:
Stanford University
Conditions:
Hodgkin Disease
Eligibility:
All Genders
4-70 years
Phase:
NA
Brief Summary
To evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation in the treatment of Hodgkin's Disease.
Detailed Description
Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease
Eligibility Criteria
Inclusion
- adequate organ function
- recurrent HD
Exclusion
- CNS disease
- no prior malignancy
Key Trial Info
Start Date :
March 1 1998
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00186251
Start Date
March 1 1998
End Date
July 1 2005
Last Update
November 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305